Literature DB >> 22923447

Clinical and histological significance of gadolinium enhancement in carotid atherosclerotic plaque.

Antoine Millon1, Loic Boussel, Marie Brevet, Jean-Louis Mathevet, Emmanuelle Canet-Soulas, Cyril Mory, Jean-Yves Scoazec, Philippe Douek.   

Abstract

BACKGROUND AND
PURPOSE: Although the ability of MRI to investigate carotid plaque composition is well established, the mechanism and the significance of plaque gadolinium (Gd) enhancement remain unknown. We evaluated clinical and histological significance of Gd enhancement of carotid plaque in patients undergoing endarterectomy for carotid stenosis.
METHODS: Sixty-nine patients scheduled for a carotid endarterectomy prospectively underwent a 3-T MRI. Carotid plaque enhancement was assessed on T1-weighted images performed before and 5 minutes after Gd injection. Enhancement was recorded according to its localization. Histological analysis was performed of the entire plaque and of the area with matched contrast enhancement on MR images.
RESULTS: Gd enhancement was observed in 59% patients. Three types of carotid plaques were identified depending on enhancement location (shoulder region, shoulder and fibrous cap, and central in the plaque). Fibrous cap rupture, intraplaque hemorrhage, and plaque Gd enhancement was significantly more frequent in symptomatic than in asymptomatic patients (P=0.043, P<0.0001, and P=0.034, respectively). After histological analysis, Gd enhancement was significantly associated with vulnerable plaque (American Heart Association VI, P=0.006), neovascularization (P<0.0001), macrophages (P=0.030), and loose fibrosis (P<0.0001). Prevalence of neovessels, macrophages, and loose fibrosis in the area of Gd enhancement was 97%, 87%, and 80%, respectively, and was different depending on the enhancement location in the plaque. Fibrous cap status and composition were different depending on the type of plaque.
CONCLUSIONS: Gd enhancement of carotid plaque is associated with vulnerable plaque phenotypes and related to an inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923447     DOI: 10.1161/STROKEAHA.112.662692

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  New developments in clinical ischemic stroke prevention and treatment and their imaging implications.

Authors:  Jeremy J Heit; Max Wintermark
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-14       Impact factor: 6.200

Review 2.  High-resolution vessel wall MRI for the evaluation of intracranial atherosclerotic disease.

Authors:  Adam de Havenon; Mahmud Mossa-Basha; Lubdha Shah; Seong-Eun Kim; Min Park; Dennis Parker; J Scott McNally
Journal:  Neuroradiology       Date:  2017-09-23       Impact factor: 2.804

Review 3.  Vessel Wall Imaging of Cerebrovascular Disorders.

Authors:  Kyle C Kern; David S Liebeskind
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

4.  Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.

Authors:  Mark E Lobatto; Claudia Calcagno; Antoine Millon; Max L Senders; Francois Fay; Philip M Robson; Sarayu Ramachandran; Tina Binderup; Maarten P M Paridaans; Steven Sensarn; Stephan Rogalla; Ronald E Gordon; Luis Cardoso; Gert Storm; Josbert M Metselaar; Christopher H Contag; Erik S G Stroes; Zahi A Fayad; Willem J M Mulder
Journal:  ACS Nano       Date:  2015-01-28       Impact factor: 15.881

5.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

6.  Gadolinium enhancement of atherosclerotic plaque in the middle cerebral artery: relation to symptoms and degree of stenosis.

Authors:  C-W Ryu; G-H Jahng; H S Shin
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-10       Impact factor: 3.825

7.  Why is middle cerebral artery plaque augmented by contrast media? A phantom study using middle cerebral artery stenotic silicon model.

Authors:  Sol-Ki Kim; Hyo Sung Kwak; Gyung Ho Chung; Seung-Bae Hwang
Journal:  Neuroradiology       Date:  2019-08-07       Impact factor: 2.804

8.  Vessel Wall Thickening and Enhancement in High-Resolution Intracranial Vessel Wall Imaging: A Predictor of Future Ischemic Events in Moyamoya Disease.

Authors:  A Kathuveetil; P N Sylaja; S Senthilvelan; C Kesavadas; M Banerjee; B Jayanand Sudhir
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-02       Impact factor: 3.825

9.  Management of asymptomatic carotid artery stenosis.

Authors:  Marc P Bonaca; Joshua Beckman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-04

Review 10.  High-resolution MRI of intracranial atherosclerotic disease.

Authors:  Chang-Woo Ryu; Hyo-Sung Kwak; Geon-Ho Jahng; Han Na Lee
Journal:  Neurointervention       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.